| Basics |
Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise treatment solutions. Its products includes the CyberKnife Systems and the TomoTherapy Systems.
|
| IPO Date: |
February 8, 2007 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$139.07M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.14 | 2.47%
|
| Avg Daily Range (30 D): |
$0.04 | 2.68%
|
| Avg Daily Range (90 D): |
$0.05 | 2.72%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.64M |
| Avg Daily Volume (30 D): |
.61M |
| Avg Daily Volume (90 D): |
.61M |
| Trade Size |
| Avg Trade Size (Sh.): |
183 |
| Avg Trade Size (Sh.) (30 D): |
195 |
| Avg Trade Size (Sh.) (90 D): |
173 |
| Institutional Trades |
| Total Inst.Trades: |
1,396 |
| Avg Inst. Trade: |
$1.26M |
| Avg Inst. Trade (30 D): |
$.5M |
| Avg Inst. Trade (90 D): |
$.5M |
| Avg Inst. Trade Volume: |
.19M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.65M |
| Avg Closing Trade (30 D): |
$.5M |
| Avg Closing Trade (90 D): |
$.5M |
| Avg Closing Volume: |
400.75K |
|
|
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$.01
|
$-.01
|
$.03
|
|
Diluted EPS
|
$.01
|
$-.01
|
$.02
|
|
Revenue
|
$ 465.25M
|
$ 113.24M
|
$ 116.17M
|
|
Gross Profit
|
$ 146.44M
|
$ 31.63M
|
$ 41.89M
|
|
Net Income / Loss
|
$ .67M
|
$ -1.3M
|
$ 2.54M
|
|
Operating Income / Loss
|
$ 10.42M
|
$ 1.05M
|
$ 4.71M
|
|
Cost of Revenue
|
$ 318.81M
|
$ 81.62M
|
$ 74.28M
|
|
Net Cash Flow
|
$ 18.09M
|
$ 14.86M
|
$ 4.26M
|
|
PE Ratio
|
149.00
|
|
|
|
